Top Markets
Coin of the day
Stryker Corporation Stryker Corporation

Stryker Corporation

SYK
Rank in Stocks #160
Stryker Corporation operates as a medical technology company. The company... Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Share Price
$336.84
Market Cap
$129.13B
Change (1 day)
2.00%
Change (1 year)
-15.94%
Country
US
Trade Stryker Corporation (SYK)

Category

P/E ratio for Stryker Corporation (SYK)
P/E ratio as of July 2026 TTM: 35.63
According to Stryker Corporation latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 35.63. At the end of 2024 the company had a P/E ratio of 45.83.
P/E ratio history for Stryker Corporation from 2000 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
2026 (TTM) 35.63 -13.89%
2025 41.38 -9.71%
2024 45.83 27.61%
2023 35.92 -8.41%
2022 39.21 -22.44%
2021 50.56 -12.14%
2020 57.54 52.66%
2019 37.69 128.39%
2018 16.50 -70.93%
2017 56.77 108.63%
2016 27.21 11.88%
2015 24.32 -64.92%
2014 69.33 145.16%
2013 28.28 75.92%
2012 16.07 12.53%
2011 14.28 -14.55%
2010 16.72 -7.52%
2009 18.08 27.26%
2008 14.20 -52.79%
2007 30.09 4.28%
2006 28.85 8.62%
2005 26.56 -36.09%
2004 41.57 6.61%
2003 38.99 -3.57%
2002 40.43 -4.42%
2001 42.30 -5.53%
2000 44.78 0.00%
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
24.71 -30.65%
US
21.15 -40.65%
IE
17.76 -50.15%
US
47.67 33.77%
US
30.88 -13.33%
US
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.